Myfortic - Treatment for Extensive cGvHD

PHASE3TerminatedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

September 30, 2006

Primary Completion Date

November 30, 2009

Study Completion Date

November 30, 2010

Conditions
Graft vs Host Disease
Interventions
DRUG

Myfortic

1440mg twice daily

DRUG

Prednisone and Cyclosporine

Prednisone and Cyclosporine given according to protocol. The drugs are tapered according to patient response

Trial Locations (8)

4031

University Hospital, Basel

6202

University Hospital, Maastricht

16132

Ospedale San Martino, Genova

46010

Hospital Clínico Universitario, Valencia

75475

Hopital St. Louis, Paris

93042

University Regensburg, Regensburg

141 86

Karolinska University Hospital, Huddinge

06260

University Faculty of Medicine, Ankara

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Novartis

INDUSTRY

lead

European Society for Blood and Marrow Transplantation

NETWORK